Literature DB >> 18829111

Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia.

Florent Poyer1, Bérénice Coquerel, Rassa Pegahi, Lionel Cazin, Vic Norris, Jean-Pierre Vannier, Marek Lamacz.   

Abstract

In children with acute lymphoblastic leukemia (ALL), leukemic cells express several members of the VEGF family and the three VEGF receptors which, via an autocrine loop are responsible for secretion of MMP-2/-9. MMP activity and the presence of elements of the autocrine loop are correlated with clinical and prognostic parameters as follows: i) high basal MMP-9 activity with tumoral syndrome, ii) MMP-2 activity with treatment failure, iii) VEGFR-1/-3 co-expression with high hemoglobin level and iv) expression of the VEGF-A 121 isoform and favorable response to treatment. These data implicate autocrine VEGF-induced secretion of MMP-2/-9 in the physiopathology of childhood ALL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829111     DOI: 10.1016/j.leukres.2008.08.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Expression of tumor necrosis factor-alpha and vascular endothelial growth factor in different zones of fetal membranes: a possible relation to onset of labor.

Authors:  Amr K Elfayomy; Shaima M Almasry
Journal:  J Mol Histol       Date:  2014-06       Impact factor: 2.611

2.  Environment-mediated drug resistance in Bcr/Abl-positive acute lymphoblastic leukemia.

Authors:  Niklas Feldhahn; Anna Arutyunyan; Sonia Stoddart; Bin Zhang; Sabine Schmidhuber; Sun-Ju Yi; Yong-Mi Kim; John Groffen; Nora Heisterkamp
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

3.  What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Authors:  P Schneider; I Dubus; F Gouel; E Legrand; J P Vannier; M Vasse
Journal:  Adv Hematol       Date:  2011-11-09

4.  Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.

Authors:  Sandrine Bouchet; Brigitte Bauvois
Journal:  Cancers (Basel)       Date:  2014-04-04       Impact factor: 6.639

5.  Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway.

Authors:  Yuan-Chun Yue; Bao-Yu Yang; Jing Lu; Shu-Wen Zhang; Liu Liu; Khaled Nassar; Xiao-Xi Xu; Xiao-Yang Pang; Jia-Ping Lv
Journal:  Microb Cell Fact       Date:  2020-11-23       Impact factor: 5.328

Review 6.  A narrative review of central nervous system involvement in acute leukemias.

Authors:  Dalma Deak; Nicolae Gorcea-Andronic; Valentina Sas; Patric Teodorescu; Catalin Constantinescu; Sabina Iluta; Sergiu Pasca; Ionut Hotea; Cristina Turcas; Vlad Moisoiu; Alina-Andreea Zimta; Simona Galdean; Jakob Steinheber; Ioana Rus; Sebastian Rauch; Cedric Richlitzki; Raluca Munteanu; Ancuta Jurj; Bobe Petrushev; Cristina Selicean; Mirela Marian; Olga Soritau; Alexandra Andries; Andrei Roman; Delia Dima; Alina Tanase; Olafur Sigurjonsson; Ciprian Tomuleasa
Journal:  Ann Transl Med       Date:  2021-01

7.  Collagenase IV plays an important role in regulating hair cycle by inducing VEGF, IGF-1, and TGF-β expression.

Authors:  Chun Hou; Yong Miao; Jin Wang; Xue Wang; Chao-Yue Chen; Zhi-Qi Hu
Journal:  Drug Des Devel Ther       Date:  2015-09-25       Impact factor: 4.162

8.  Over-expression of ARHGAP18 suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways.

Authors:  Yan Li; Shan Ji; Liye Fu; Tao Jiang; Di Wu; Fandong Meng
Journal:  Onco Targets Ther       Date:  2018-01-09       Impact factor: 4.147

9.  VEGF promotes migration and invasion by regulating EMT and MMPs in nasopharyngeal carcinoma.

Authors:  Li Chen; Guoxiang Lin; Kaihua Chen; Renba Liang; Fangzhu Wan; Chuxiao Zhang; Ge Tian; Xiaodong Zhu
Journal:  J Cancer       Date:  2020-10-21       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.